**Core Concept**
The question is testing the student's knowledge of Disease-Modifying Antirheumatic Drugs (DMARDs), a class of medications used to treat rheumatoid arthritis and other autoimmune diseases. DMARDs work by suppressing the immune system to prevent joint damage and slow disease progression.

**Why the Correct Answer is Right**
The correct answer is a drug that does not belong to the DMARD class. DMARDs typically include medications such as methotrexate, hydroxychloroquine, sulfasalazine, and leflunomide, which work by inhibiting enzymes, modulating cytokine production, or blocking immune cell activation. Drugs like NSAIDs, corticosteroids, and biologics may be used to treat rheumatoid arthritis symptoms but are not considered DMARDs.

**Why Each Wrong Option is Incorrect**
* **Option A:** Methotrexate is a classic DMARD that inhibits dihydrofolate reductase, leading to reduced DNA synthesis and cell proliferation.
* **Option B:** Hydroxychloroquine is a DMARD that modulates the immune response by increasing the pH of lysosomes and inhibiting antigen presentation.
* **Option C:** Leflunomide is a DMARD that inhibits dihydroorotate dehydrogenase, which is essential for pyrimidine synthesis and cell proliferation.

**Clinical Pearl / High-Yield Fact**
When treating rheumatoid arthritis, it's essential to start with a DMARD as soon as possible, ideally within 3 months of diagnosis, to achieve optimal disease control and prevent joint damage.

**Correct Answer:** A.